A detailed history of Arjuna Capital transactions in Amgen Inc stock. As of the latest transaction made, Arjuna Capital holds 25,129 shares of AMGN stock, worth $8.06 Million. This represents 2.15% of its overall portfolio holdings.

Number of Shares
25,129
Previous 24,142 4.09%
Holding current value
$8.06 Million
Previous $6.86 Million 14.38%
% of portfolio
2.15%
Previous 1.98%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$262.75 - $319.31 $259,334 - $315,158
987 Added 4.09%
25,129 $7.85 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $2.39 Million - $2.89 Million
8,893 Added 58.32%
24,142 $6.86 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $478,414 - $539,708
1,871 Added 13.99%
15,249 $4.39 Million
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $2.07 Million - $2.57 Million
-9,475 Reduced 41.46%
13,378 $3.6 Million
Q2 2023

Aug 09, 2023

BUY
$214.27 - $253.37 $131,561 - $155,569
614 Added 2.76%
22,853 $5.07 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $184,696 - $225,113
818 Added 3.82%
22,239 $5.38 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $165,130 - $209,818
721 Added 3.48%
21,421 $5.63 Million
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $284,166 - $320,487
1,266 Added 6.51%
20,700 $4.67 Million
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $78,210 - $87,034
339 Added 1.78%
19,434 $4.73 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $310,486 - $343,479
-1,416 Reduced 6.9%
19,095 $4.62 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $12,728 - $14,566
-64 Reduced 0.31%
20,511 $4.61 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $236,893 - $277,549
1,116 Added 5.74%
20,575 $4.38 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $237,083 - $263,027
1,015 Added 5.5%
19,459 $4.74 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $255,418 - $297,648
1,151 Added 6.66%
18,444 $4.59 Million
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $90,014 - $107,190
416 Added 2.46%
17,293 $3.98 Million
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $53,969 - $60,018
230 Added 1.38%
16,877 $4.29 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $278,516 - $341,777
-1,408 Reduced 7.8%
16,647 $3.93 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $53,943 - $71,543
-296 Reduced 1.61%
18,055 $3.66 Million
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $102,930 - $132,300
-544 Reduced 2.88%
18,351 $4.42 Million
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $43,005 - $51,529
247 Added 1.32%
18,895 $3.66 Million
Q2 2019

Aug 21, 2019

BUY
$166.7 - $195.41 $34,840 - $40,840
209 Added 1.13%
18,648 $3.44 Million
Q2 2019

Aug 08, 2019

BUY
$166.7 - $195.41 $128,192 - $150,270
769 Added 4.35%
18,439 $3.4 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $32,375 - $36,494
-179 Reduced 1.0%
17,670 $3.36 Million
Q4 2018

Jan 31, 2019

SELL
$178.4 - $208.25 $47,454 - $55,394
-266 Reduced 1.47%
17,849 $3.48 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $23,161 - $26,111
125 Added 0.69%
18,115 $3.76 Million
Q2 2018

Aug 01, 2018

BUY
$166.05 - $186.51 $23,579 - $26,484
142 Added 0.8%
17,990 $3.32 Million
Q1 2018

Apr 24, 2018

BUY
$169.43 - $198.0 $548,275 - $640,728
3,236 Added 22.15%
17,848 $3.04 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $2.47 Million - $2.76 Million
14,612
14,612 $2.54 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Arjuna Capital Portfolio

Follow Arjuna Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arjuna Capital, based on Form 13F filings with the SEC.

News

Stay updated on Arjuna Capital with notifications on news.